More awesome advice from ⁦Susan C. Modesitt, MD⁩ at Fellows Forum.

📽️ Watch the SGO Surgical Films from #SGO2024 !

What do you think David Cohn, MD, MBA??
#gynoncology 🙂

sciencedirect.com/journal/gyneco…

Dr. Hutchcraft (Gynecologic Oncology reports editorial fellow) has been doing amazing tweets to highlight the incredible work being presented at Winter SGO. @GynOncJnls SGO

So appreciative of both of our amazing editorial teams’ ability to quickly publish research that matters for our patients and our society. Happy Holidays! @GynOncJnls SGO

Dr. Dilley doing an excellent recap of the GYN ONC session from DDHO, check it out:/)Sarah Dilley Jill Remick Emory Gyn Ob

Dr. Dilley goes over treatment and prevention option for our cervical cancer patients, amazing overview. Winship Cancer Institute of Emory University Emory Gyn Ob Sarah Dilley

So fun to discuss how to best treat our cancer patients with a friend and colleague. Dr. Remick rocks. Jill Remick Sarah Dilley Winship Cancer Institute of Emory University

Thrilled for our first impact factor but, more importantly, thrilled at the growth and progress of the journal to immediately publish work that improves care for gynecologic oncology patients. Kudos to our authors, reviewers and editorial team. @GynOncJnls SGO

Amazing year for our specialty and our journals to be able to share the knowledge that will continue to improve our patients lives. Thank you for following!

Congrats 🎉 to Samantha Leite who wins the #GynOncReports article 💵 fee waiver for following @GynOncJnls during the SGO #SGOMtg in Tampa ☀️ 🏝️ Susan C. Modesitt, MD

Very low % Serous carcinomas in early stage trials: ACTION (35%), ICON1 (30%), GOG 157 (23%).
Underestimating the recurrence rate????
doi.org/10.1016/j.gore…

Thank you Dr. Manning-Geist for this commentary. Ovarian cancer rates have been dropping in the US; likely due in part to increasing use of risk reducing surgeries in genetically high risk women. Prevention is FAR better than early cancer detection. SGO @GynOncJnls

Free Article Publishing Charge (APC) alert 🔔🚨 Follow @GynOncJnls during the SGO Annual Meeting #SGO2023 #SGOMtg and have a chance to win an APC waiver for #GynOncReports ☀️ 🏝️ #Tampa

Our journal is dedicated to improving our patients outcomes…and everyone plays a pivotal role. @GynOncJnls SGO

So proud of the work of our amazing editorial team. Excited about all that will be coming this year

Preventing future ovarian cancer can be a team effort. All surgeons can help by considering opportunistic salpingectomy at the time of any abdominal surgery. @GynOncJnls SGO nam11.safelinks.protection.outlook.com/?url=https%3A%…

Team pub led by Emory Nursing postdoc Zahra A. Barandouzi etal on Assoc's Betwn Social Determinants of Health (SDOH) & Psychoneurologic Symptoms (PNS) in Women w Gyne #Cancers : Mar 2023, ONF, 50(2) Results: low educ, income, nemployment &disadvantaged neighborhoods associated w more PNS

The February issue of Gynecologic Oncology is available now!
ow.ly/Q2Un50MRTIV @GynOncJnls

Dr. Straughn is an amazing physician, deputy editor AND a leader in quality research. Check out his editorial and two important QI papers in GYN Onc reports. @GynOncJnls SGO UAB OB/GYN Residency Program

Happy new yea from the GYN Onc Reports team. Excited about 2023 with new features including mini reviews, continuing SGO journal clubs and establishing an opportunity for a gynecologic oncology fellow to join our editorial leadership team. @GynOncJnls SGO David Cohn, MD, MBA